Skip to main content
Log in

The combination of insulin-like growth factor 1 and erythropoietin protects against ischemic spinal cord injury in rabbits

  • Original Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Introduction

Insulin-like growth factor 1 (IGF-1) and erythropoietin (EPO) have been reported to independently protect against ischemic spinal cord injury in rabbits. In the present study, we investigated whether the combination of IGF-1 and EPO protects against ischemic spinal cord injury in rabbits.

Methods

Animals were assigned to 1 of 4 groups (n = 6 in each): a control group (saline), an IGF-1 group (IGF-1 0.3 mg/kg), an EPO group (EPO 800 U/kg), or an IGF-1 + EPO group (IGF-1 0.3 mg/kg + EPO 800 U/kg). Spinal cord ischemia was produced by occluding the abdominal aorta for 15 min. Saline, IGF-1, and EPO were administered intravenously just after the start of reperfusion. Hindlimb motor function was assessed daily for 7 days, after which histopathological evaluation was performed. To analyze phosphorylation of signal transduction molecules, animals were assigned to 1 of the 4 groups (n = 8 in each). Spinal cord ischemia and the treatment were the same as those described above. The spinal cords were removed at 15 or 30 min after reperfusion and used to analyze phosphorylation of signal transduction molecules. Four animals served as the preischemic control, and the spinal cord was removed just before the start of ischemia.

Results

In the IGF-1 + EPO group, both neurological and histopathological outcomes were significantly improved as compared to the control group, which was consistent with the increase of Janus kinase-2 (JAK2) phosphorylation.

Conclusions

The combination of IGF-1 and EPO protects against ischemic spinal cord injury in rabbits. JAK2 might contribute to the protective effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nakao Y, Otani H, Yamamura T, Hattori R, Osako M, Imamura H. Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia. J Thorac Cardiovasc Surg. 2001;122:136–43.

    Article  CAS  PubMed  Google Scholar 

  2. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K, Sagiroglu E, Cerami A, Brines M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA. 2002;99:2258–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Smith PD, Puskas F, Fullerton DA, Meng X, Cho D, Cleveland JC Jr, Weyant MJ, Reece TB. Attenuation of spinal cord ischemia and reperfusion injury by erythropoietin. J Thorac Cardiovasc Surg. 2011;141:256–60.

    Article  CAS  PubMed  Google Scholar 

  4. Digicaylioglu M, Garden G, Timberlake S, Fletcher L, Lipton SA. Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc Natl Acad Sci USA. 2004;101:9855–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Matsumoto M, Iida Y, Sakabe T, Sano T, Ishikawa T, Nakakimura K. Mild and moderate hypothermia provide better protection than a burst-suppression dose of thiopental against ischemic spinal cord injury in rabbits. Anesthesiology. 1997;86:1120–7.

    Article  CAS  PubMed  Google Scholar 

  6. Drummond JC, Moore SS. The influence of dextrose administration on neurologic outcome after temporary spinal cord ischemia in the rabbit. Anesthesiology. 1989;70:64–70.

    Article  CAS  PubMed  Google Scholar 

  7. Mizukami Y, Iwamatsu A, Aki T, Kimura M, Nakamura K, Nao T, Okusa T, Matsuzaki M, Yoshida K, Kobayashi S. ERK1/2 regulates intracellular ATP levels through alpha-enolase expression in cardiomyocytes exposed to ischemic hypoxia and reoxygenation. J Biol Chem. 2004;279:50120–31.

    Article  CAS  PubMed  Google Scholar 

  8. Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C, Nikolics K. A role for IGF-1 in the rescue of CNS neurons following hypoxic–ischemic injury. Biochem Biophys Res Commun. 1992;182:593–9.

    Article  CAS  PubMed  Google Scholar 

  9. Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood–brain barrier. Endocrinology. 1994;135:1753–61.

    CAS  PubMed  Google Scholar 

  10. Sakanaka M, Wen T-C, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA. 1998;95:4635–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA. 2000;97:10526–31.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Nagamizo D, Tsuruta S, Matsumoto M, Matayoshi H, Yamashita A, Sakabe T. Tight glycemic control by insulin, started in the preischemic, but not postischemic, period, protects against ischemic spinal cord injury in rabbits. Anesth Analg. 2007;105:1397–403.

    Article  CAS  PubMed  Google Scholar 

  13. Shirasawa Y, Matsumoto M, Yoshimura M, Yamashita A, Fukuda S, Ishida K, Sakabe T. Does high-dose opioid anesthesia exacerbate ischemic spinal cord injury in rabbits? J Anesth. 2009;23:242–8.

    Article  PubMed  Google Scholar 

  14. Kirken RA, Rui H, Malabarba MG, Farrar WL. Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. J Biol Chem. 1994;269:19136–41.

    CAS  PubMed  Google Scholar 

  15. Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood. 1994;84:1501–7.

    CAS  PubMed  Google Scholar 

  16. Zong CS, Chan J, Levy DE, Horvath C, Sadowski HB, Wang LH. Mechanism of STAT3 activation by insulin-like growth factor I receptor. J Biol Chem. 2000;275:15099–105.

    Article  CAS  PubMed  Google Scholar 

  17. Yadav A, Kalita A, Dhillon S, Banerjee K. JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J Biol Chem. 2005;280:31830–40.

    Article  CAS  PubMed  Google Scholar 

  18. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8:495–505.

    PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 21591974) from the Japan Society for the Promotion of Science.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mishiya Matsumoto.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Utada, K., Ishida, K., Tohyama, S. et al. The combination of insulin-like growth factor 1 and erythropoietin protects against ischemic spinal cord injury in rabbits. J Anesth 29, 741–748 (2015). https://doi.org/10.1007/s00540-015-2031-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-015-2031-y

Keywords

Navigation